The Pharmaceutical Studies Reader.Series: Wiley Blackwell Readers in Anthropology SerPublisher: New York : John Wiley & Sons, Incorporated, 2015Copyright date: ©2015Edition: 1st edDescription: 1 online resource (296 pages)Content type:
- online resource
- HD9665.5 -- .P437 2015eb
|Item type||Current library||Call number||Status||Date due||Barcode||Item holds|
Intro -- Title Page -- Copyright Page -- Contents -- Acknowledgements -- Chapter 1 Introduction -- Why Study Pharmaceuticals? -- A Prehistory of Pharmaceutical Studies -- Key Themes in Pharmaceutical Studies -- Guide to this Volume -- Notes -- Part I Pharmaceutical Lives -- Chapter 2 The Pharmaceuticalisation of Society? A Framework for Analysis -- Introduction -- Definition, Delineation and Dynamics: What is Pharmaceuticalisation? -- Trends and Transformations -- Discussion -- References -- Chapter 3 Pharmaceutical Witnessing: Drugs for Life in an Era of Direct-to-Consumer Advertising -- Remaking the Body at Risk -- Awareness Through Education -- Personalizing the Risk -- Motivation to Informing Self-diagnosis -- Convincing the Doctor, the Critical Moment -- Branded Compliance -- Conclusion -- Note -- References -- Part II New Drugs, Diseases, and Identities -- Chapter 4 Releasing the Flood Waters: Diuril and the Reshaping of Hypertension -- Introduction -- Diuril in the Life of the Pharmaceutical Firm -- Attachment: Diuril Meets Hypertension -- Clinical Research as a Marketing Arena -- Public Relations and Popular Media -- "Ethical Marketing": The Detail Man and the Diuril Man -- Reception: Diuril and Hypertension in Practice -- Expanding the Ranks of the Treatable -- Detaching "Diuril" from Hypertension -- Notes -- Chapter 5 Dep®ession and Consum♀tion: Psychopharmaceuticals, Branding, and New Identity Practices -- Introduction -- Branded Identity and "Symbolic Mistakes": The New Social Lives of Pharmaceuticals -- Markets, Molecules and Meanings -- Sarafeminism? -- Premenstrual Dysphoric Disorder in the Making -- Symbolic Side Effects -- Marketing (and) Medical Turf: Symbolic Fallout -- Conclusions -- Notes -- References -- Chapter 6 BiDil: Medicating the Intersection of Race and Heart Failure -- Considering Heart Failure as a Disease Category.
BiDil's Contingent History: V-HeIT to A-HeIT -- Too High a Price? -- Pharmakon -- The Material-semiotic -- Conclusion -- Notes -- Works Cited -- Chapter 7 Manufacturing Desire: The Commodification of Female Sexual Dysfunction -- New Diagnoses for New Drugs: Creating a Market -- The Commodification of Continuing Medical Education -- The Celebrity of the 'Sex Expert': Media and the Commodification of Female Sexual Dysfunction -- Robust Pipelines -- Notes -- References -- Part III Drugs and the Circulation of Medical Knowledge -- Chapter 8 Following the Script: How Drug Reps Make Friends and Influence Doctors -- Better than You Know Yourself -- Script Tracking -- The Value of Samples -- Funding Friendship -- Conclusion -- References -- Chapter 9 Getting to Yes: Corporate Power and the Creation of a Psychopharmaceutical Blockbuster -- From Schizophrenia to Complicated Moods: The Evolution of Zyprexa -- Marketing Channels and Synergistic Power: Conclusion -- Notes -- References -- Chapter 10 Pushing Knowledge in the Drug Industry: Ghost-Managed Science -- Introduction -- A Sample Manuscript -- Publication Planning 101/201: An Insider View of the Field -- Marketing -- Medical Journals -- Authorship and its Limits -- Creating Knowledge Through Mediation -- Changing Trajectories? -- Discussion -- Notes -- References -- Chapter 11 Transcultural Medicine: A Multi-Sited Ethnography on the Scientific-Industrial Networking of Korean Medicine -- A Brief Modern History of Korean Medicine and its Transformation -- KM Doctors' Global Experiences: Biographical Accounts -- Hybrid and Modernized Practice: The Production of Hybrid KM Treatments in the KM Clinic -- Laboratory Practice and the Scientization of Herbal Therapies -- Network of Networks: Industrialization Process of Herbal Medicine in the Purimed Company.
Transcultural Medicine and Emergence of New Medical Assemblage in Global Power Relations -- Conclusion -- Notes -- References -- Part IV Political and Moral Economies of Pharmaceutical Research -- Chapter 12 Uncommon Trajectories: Steroid Hormones, Mexican Peasants, and the Search for a Wild Yam -- Introduction -- Hormones in the Laboratory -- In Search of a Wild Yam -- The Birth of Syntex -- George Rosenkranz and the Study of Chemistry in Mexico -- Human Faces Beyond the Laboratories: Mexicans Search for Barbasco -- Carl Djerassi: Syntex, Cortisone, and an Amazing Mexican Yam -- Conclusion -- Notes -- References -- Chapter 13 "Ready-to-Recruit" or "Ready-to-Consent" Populations?: Informed Consent and the Limits of Subject Autonomy -- Recruitment and Informed Consent -- Analysis of Advertisements -- Participation and Informed Consent -- Conclusion -- Notes -- References -- Chapter 14 Clinical Trials Offshored: On Private Sector Science and Public Health -- Clinical Trial Environments -- Pharmaceutical Capital: Contract Research in Brief -- Constructing Global Subjects -- Keeping the Clinical Trial Market in Poland -- 'Pharmaceuticals are the New Gold' -- Notes -- References -- Chapter 15 The Experimental Machinery of Global Clinical Trials: Case Studies from India -- The Indian Clinical Trials Landscape -- A Critique of the Global Biomedical Economy: Expropriation, Exploitation, and the Structural Violence of Biocapital -- Notes -- Part V Intellectual Property in Local and Global Markets -- Chapter 16 Intellectual Property and Public Health: Copying of HIV/AIDS Drugs by Brazilian Public and Private Pharmaceutical Laboratories -- Introduction -- Public Health Policy and Local Production of Generic Drugs -- The Unpatentable Status of Drugs in Brazil from 1945 to 1996: A Licit Copying Regime -- Copying and Technological Learning.
Copying and Pharmaceutical Innovations -- Conflict Between the Brazilian Health Ministry and International Laboratories: Negotiations on Prices and Compulsory Licences -- Conclusions -- Notes -- Chapter 17 Global Pharmaceutical Markets and Corporate Citizenship: The Case of Novartis' Anti-Cancer Drug Glivec -- Novartis versus the Government of India -- Pharmaceutical Citizens versus Novartis -- Pharmaceutical Citizens Pro Novartis -- Give to the Poor to Take from the Rich -- Note -- References -- Chapter 18 Generic Medicines and the Question of the Similar -- A New Market? -- The Similar and the "Similar" -- Generics and the Social Studies of Science and Technology -- Notes -- References -- Index -- EULA.
The Pharmaceutical Studies Reader is an engaging survey of the field that brings together provocative, multi-disciplinary scholarship examining the interplay of medical science, clinical practice, consumerism, and the healthcare marketplace. Draws on anthropological, historical, and sociological approaches to explore the social life of pharmaceuticals with special emphasis on their production, circulation, and consumption Covers topics such as the role of drugs in shaping taxonomies of disease, the evolution of prescribing habits, ethical dimensions of pharmaceuticals, clinical trials, and drug research and marketing in the age of globalization Offers a compelling, contextually-rich treatment of the topic that exposes readers to a variety of approaches, ideas, and frameworks Provides an accessible introduction for readers with no previous background in this area.
Description based on publisher supplied metadata and other sources.
Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2019. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.